ZA879593B - Nasal solutions - Google Patents

Nasal solutions

Info

Publication number
ZA879593B
ZA879593B ZA879593A ZA879593A ZA879593B ZA 879593 B ZA879593 B ZA 879593B ZA 879593 A ZA879593 A ZA 879593A ZA 879593 A ZA879593 A ZA 879593A ZA 879593 B ZA879593 B ZA 879593B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
human calcitonin
nasal solutions
meterable
derivative
Prior art date
Application number
ZA879593A
Inventor
Geller Leo
Glanzmann Peter
Original Assignee
Ciba-Geigy Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba-Geigy Ag. filed Critical Ciba-Geigy Ag.
Publication of ZA879593B publication Critical patent/ZA879593B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions in the form of aqueous solutions for the nasal administration of human calcitonin in meterable amounts, a process for the production of these pharmaceutical compositions and their use are described. The pharmaceutical composition contains a) a therapeutically effective amount of human calcitonin or a derivative thereof, b) viscosity-increasing swelling agents and c) an aqueous vehicle optionally containing isotonic additives and/or additional auxiliaries.
ZA879593A 1986-12-23 1987-12-22 Nasal solutions ZA879593B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH520086 1986-12-23

Publications (1)

Publication Number Publication Date
ZA879593B true ZA879593B (en) 1988-06-22

Family

ID=4289609

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879593A ZA879593B (en) 1986-12-23 1987-12-22 Nasal solutions

Country Status (15)

Country Link
EP (1) EP0277462B1 (en)
JP (1) JPS63166832A (en)
AT (1) ATE75404T1 (en)
AU (1) AU608268B2 (en)
CA (1) CA1322330C (en)
DE (1) DE3778682D1 (en)
DK (1) DK166714B1 (en)
ES (1) ES2032303T3 (en)
GR (1) GR3004585T3 (en)
IL (1) IL84861A (en)
MY (1) MY102411A (en)
NZ (1) NZ223005A (en)
PH (1) PH24802A (en)
PT (1) PT86436B (en)
ZA (1) ZA879593B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
AU638128B2 (en) * 1990-04-10 1993-06-17 University Of Melbourne, The Calcitonin gene related peptide for the treatment of undescended testicles
JPH05506223A (en) * 1990-04-10 1993-09-16 ザ ユニバーシティー オブ メルボルン Calcitonin gene-related peptide for treatment of descended testicles
JP3179538B2 (en) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト Aqueous solution of stable human calcitonin
GB9108634D0 (en) * 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
EP0803255A4 (en) * 1994-06-03 1999-06-30 Tsumura & Co Medicinal composition
IL136591A (en) * 1998-01-30 2005-08-31 Novartis Consumer Health Sa Nasal pharmaceutical solutions
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026073A1 (en) 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE
JP2002154989A (en) * 2000-11-14 2002-05-28 Lion Corp Ophthalmic composition and composition having improved retention of medicine in biological mucosa
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
CH657858A5 (en) * 1983-06-27 1986-09-30 Ciba Geigy Ag SUBSTANCE FROM THE CALCITONINE GROUP.
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
DE3500268A1 (en) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt PREPARATIONS WITH DELAYED EFFECT, METHOD FOR THE PRODUCTION THEREOF AND CORRESPONDING AGENTS FOR THE HUMAN OR. VETERINE MEDICAL APPLICATION
JPS61194034A (en) * 1985-02-25 1986-08-28 Teijin Ltd Powdery composition for transnasal administration

Also Published As

Publication number Publication date
DK166714B1 (en) 1993-07-05
ATE75404T1 (en) 1992-05-15
GR3004585T3 (en) 1993-04-28
DK676987D0 (en) 1987-12-22
AU608268B2 (en) 1991-03-28
MY102411A (en) 1992-06-17
DK676987A (en) 1988-06-24
IL84861A (en) 1992-09-06
EP0277462A1 (en) 1988-08-10
DE3778682D1 (en) 1992-06-04
PT86436A (en) 1988-01-01
CA1322330C (en) 1993-09-21
PT86436B (en) 1990-11-20
JPS63166832A (en) 1988-07-11
EP0277462B1 (en) 1992-04-29
ES2032303T3 (en) 1993-02-01
NZ223005A (en) 1990-07-26
PH24802A (en) 1990-10-30
AU8295587A (en) 1988-06-23

Similar Documents

Publication Publication Date Title
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
DE3875025T2 (en) COMPOSITION CONTAINING CALCITONIN FOR NASAL ADMINISTRATION.
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
MY101026A (en) An improved method for administering insulin.
EP0252227A3 (en) Use of inositol triphosphate in the treatment of metal intoxication
MY101784A (en) Novel pharmacological compounds
GR3004585T3 (en)
EP0273277A3 (en) Pharmaceutical composition comprising 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) in treating patients infected with retrovirus
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
ATE56138T1 (en) PERFLUOROCARBONS AS VEHICLES FOR DRUG DELIVERY.
EP0153152A3 (en) (2-oxo-1,2,3,5-tetrahydroimidazo-/2,1-b/quinnazolinyl)-oxyalkylamides, their preparation, compositions containing them and their use in making medicaments
ZA876411B (en) A substance or composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-dideoxy-2',3'-didehydrocytidine)for use in treating patients infected with retroviruses
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
DE69420440D1 (en) Pharmaceutical composition containing a general anesthetic and selegiline
JPS5551019A (en) Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof
DK277387A (en) THERAPEUTIC TOPICAL COMPOSITION AGAINST A HYPERPROLIFIING EPITHAL DISEASE
IT1223132B (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
IL76458A0 (en) Polyether ionophore,its preparation and pharmaceutical and veterinary preparations containing it
ES2029161A6 (en) Process for the preparation of zinc carbocysteinate compositions and their use in hepatopathies.
JO1531B1 (en) Novel pharmacological compounds
IT8819541A0 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.